Consumer Goods & Retail Global On demand · 24-48h

Global Urinary Leg Bags & Systems Market Strategic Research Report

Global Urinary Leg Bags & Systems Market Strategic Research …

$3,500 USD

Strategic Research Report

Global Urinary Leg Bags & Systems Market

$1.01B2025

5.2%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Small: 100–500 ml, Medium: 501–800 ml, Large: 801–1000 ml

By Application: Disposable, Reusable

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Coloplast, Hollister, Bard (BD), Teleflex, ConvaTec, Medline, Cardinal Health, Flexicare, Rusch (Teleflex), Vogt Medical, Plasti‑Med, Amsino, Manfred Sauer, B Braun, Smiths Medical, Drive DeVilbiss Healthcare, Kare Medical, Medtronic, Well Lead Medical, SunMed, Dynarex, Cure Medical

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 156 pages

Market size 2025

$1.01B

Billion USD

Forecast CAGR

5.2%

2025-2032

Forecast 2032

$1.4B

Projected

Regions

Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Urinary Leg Bags & Systems market size is predicted to grow from US$ 1,006 million in 2025 to US$ 1,416 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Urinary Leg Bags & Systems are medical urination devices used to collect urine from patients and are secured to the leg for mobility and daily activities. They are typically connected to a catheter (Foley catheter, external catheter, etc.) and consist of a collection bag, drainage tube, check valve, drain valve, and leg strap securing system. This system primarily addresses the challenges faced by long-term catheterized patients, including inability to urinate independently, limited mobility, nighttime urination needs, and difficulties in urine management in hospitals and homes. It allows patients to maintain privacy, comfort, and hygiene during mobility, walking, and rehabilitation. Urinary leg bags enable long-term catheterized patients to maintain mobility while achieving safe, discreet, and hygienic urine management. The average price of this product is approximately $2.50 per unit, with global sales of approximately 411 million units.

Global key Urinary Leg Bags & Systems players cover Coloplast, Hollister, Bard (BD), Teleflex, ConvaTec, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Urinary Leg Bags & Systems market?

What factors are driving Urinary Leg Bags & Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Urinary Leg Bags & Systems market opportunities vary by end market size?

How does Urinary Leg Bags & Systems break out by Type, by Application?

This report presents a comprehensive overview of the global Urinary Leg Bags & Systems market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Small: 100–500 ml
Medium: 501–800 ml
Large: 801–1000 ml

Segment by Material

PVC
PE/PU
Silicone
Other

Segment by Application

Hospitals
Long-term Care Facilities
Home Healthcare
Other

Segment by Application

Disposable
Reusable

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Urinary Leg Bags & Systems market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Disposable, Reusable evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Urinary Leg Bags & Systems Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 5.2%

Regional growth momentum

Market share by segment

Key metrics

Base value

$1.01B

2025

Forecast

$1.4B

2032

CAGR

5.2%

2025–2032

Regions

global

Key companies

ColoplastHollisterBard (BD)TeleflexConvaTecMedlineCardinal HealthFlexicare

Segments covered in this report

By Type

Small: 100–500 mlMedium: 501–800 mlLarge: 801–1000 ml

By Application

DisposableReusable

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Small: 100–500 ml
3.1.3 Medium: 501–800 ml
3.1.4 Large: 801–1000 ml
3.1.5 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Disposable
4.1.3 Reusable
4.1.4 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Coloplast
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Hollister
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Bard (BD)
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Teleflex
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 ConvaTec
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 Medline
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Cardinal Health
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Flexicare
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Rusch (Teleflex)
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Vogt Medical
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Plasti‑Med
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Amsino
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 Manfred Sauer
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 B Braun
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 Smiths Medical
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)
8.16 Drive DeVilbiss Healthcare
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2026–2032)
8.17 Kare Medical
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2026–2032)
8.18 Medtronic
8.18.1 Company Overview
8.18.2 Key Products & Segments
8.18.3 Financial Performance (2023–2025)
8.18.4 Business Strategy
8.18.5 SWOT Analysis
8.18.6 Strategic Implications (2026–2032)
8.19 Well Lead Medical
8.19.1 Company Overview
8.19.2 Key Products & Segments
8.19.3 Financial Performance (2023–2025)
8.19.4 Business Strategy
8.19.5 SWOT Analysis
8.19.6 Strategic Implications (2026–2032)
8.20 SunMed
8.20.1 Company Overview
8.20.2 Key Products & Segments
8.20.3 Financial Performance (2023–2025)
8.20.4 Business Strategy
8.20.5 SWOT Analysis
8.20.6 Strategic Implications (2026–2032)
8.21 Dynarex
8.21.1 Company Overview
8.21.2 Key Products & Segments
8.21.3 Financial Performance (2023–2025)
8.21.4 Business Strategy
8.21.5 SWOT Analysis
8.21.6 Strategic Implications (2026–2032)
8.22 Cure Medical
8.22.1 Company Overview
8.22.2 Key Products & Segments
8.22.3 Financial Performance (2023–2025)
8.22.4 Business Strategy
8.22.5 SWOT Analysis
8.22.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Urinary Leg Bags & Systems market?

The global Urinary Leg Bags & Systems market is estimated at US$ 1.01 billion in 2025 (base year) and is projected to reach US$ 1.42 billion by 2032.

How fast is the Urinary Leg Bags & Systems market expected to grow?

The market is expected to grow at a CAGR of 5.2% from 2026 to 2032, expanding from US$ 1.01 billion in 2025 to US$ 1.42 billion in 2032, roughly 1.4 times its base-year value.

What does the Urinary Leg Bags & Systems market cover?

What are the main segments of the Urinary Leg Bags & Systems market by type?

By type, the market is segmented into Small: 100–500 ml, Medium: 501–800 ml and Large: 801–1000 ml.

Which applications drive demand in the Urinary Leg Bags & Systems market?

Key applications covered include Disposable and Reusable.

Who are the key players in the Urinary Leg Bags & Systems market?

Key players profiled include Coloplast, Hollister, Bard (BD), Teleflex, ConvaTec, Medline, Cardinal Health and Flexicare, among 22 companies covered in total.

Which regions and countries are covered for Urinary Leg Bags & Systems?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What is driving growth in the Urinary Leg Bags & Systems market?

What factors are driving Urinary Leg Bags & Systems market growth, globally and by region?

What challenges does the Urinary Leg Bags & Systems market face?

This system primarily addresses the challenges faced by long-term catheterized patients, including inability to urinate independently, limited mobility, nighttime urination needs, and difficulties in urine management in hospitals and homes.

Who should buy the Urinary Leg Bags & Systems market report?

The report is intended for manufacturers and solution providers, distributors and end users in Disposable and Reusable, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Urinary Leg Bags & Systems market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.